Two Sigma Securities’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Two Sigma Securities’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,328	Closed	-$7.94K	–	3632
2023 Q2	$7.94K	Buy	11,328 +1,102	+11%	+$670	﹤0.01%	2622
2023 Q1	$6.75K	Buy	+10,226	New	+$17.1K	﹤0.01%	2501
2022 Q4	–	Sell	-10,865	Closed	-$19K	–	3427
2022 Q3	$19K	Buy	10,865 +7,969	+275%	+$23.1K	﹤0.01%	2308
2022 Q2	$16K	Buy	+2,896	New	+$26.2K	﹤0.01%	1988
2021 Q3	–	Sell	-697	Closed	-$30K	–	2061
2021 Q2	$30K	Buy	+697	New	+$28.7K	﹤0.01%	1434
2016 Q2	–	Sell	-6	Closed	-$8K	–	546
2016 Q1	$8K	Buy	+6	New	+$6.92K	0.01%	267

Other funds holding FRTX

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Securities's FRTX Position: Q3 2023 in Review

Two Sigma Securities sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2023, closing a stake of 11,328 shares — an estimated $7.94K sold.

Two Sigma Securities first reported a position in FRTX in Q1 2016 and held it in 6 quarters. The position peaked at $30K in Q2 2021. 15 funds tracked by Wall St. Rank hold FRTX as of Q3 2023.

Two Sigma Securities reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Securities sold 11,328 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $7.94K.
Two Sigma Securities first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2016 and held it in 6 quarters.
Two Sigma Securities's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $30K in Q2 2021.
15 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.